AnalystsReni J. Benjamin
Reni J. Benjamin's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 24%
#1242 out of 5253 analysts
Average Return
+15.94%
Win Rate
55%12 out of 22
Risk vs Reward
Poor
Good

Reni J. Benjamin's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Prelude Therapeutics IncPRLD
+369.28%$0.94$4.43
2025-08-17 -
2026-04-16
Buy
Summit Therapeutics IncSMMT
+68.65%$14.48$24.42
2026-01-29 -
2026-04-16
Buy
Kura Oncology IncKURA
+61.37%$5.54$8.94
2025-08-10 -
2026-04-16
Buy
Bicara Therapeutics IncBCAX
+41.51%$16.91$23.93
2026-01-28 -
2026-04-16
Buy
IMMIX Biopharma IncIMMX
+22.21%$8.15$9.96
2026-03-26 -
2026-04-16
Buy

Reni J. Benjamin Analyst Color

Get additional color on Reni J. Benjamin's coverage of popular stocks

Reni J. Benjamin's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Whitehawk Therapeutics IncWHWK
1Buy$8.00+89.13%Initiates Coverage On
a day ago
Allogene Therapeutics IncALLO
1Buy$8.00+237.55%Maintains
3 days ago
Bicara Therapeutics IncBCAX
2Buy$31.00+29.54%Reiterates
17 days ago
IMMIX Biopharma IncIMMX
1Buy$23.00+130.92%Reiterates
21 days ago
Lyell Immunopharma IncLYEL
1Buy$34.00+43.46%Initiates Coverage On
a month ago
Iovance Biotherapeutics IncIOVA
2Buy$5.00+31.58%Upgrades
a month ago
Immutep LtdIMMP
2Buy$10.00+1,624.14%Initiates Coverage On
2 months ago
Summit Therapeutics IncSMMT
4Buy$40.00+63.80%Reiterates
3 months ago
Zymeworks IncZYME
1Buy$32.00+17.65%Initiates Coverage On
4 months ago
Beone Medicines LtdONC
1Buy$396.00+23.48%Maintains
5 months ago
Sana Biotechnology IncSANA
1Buy$8.00+130.55%Maintains
6 months ago
Kura Oncology IncKURA
2Buy$24.00+168.46%Reiterates
6 months ago
Werewolf Therapeutics IncHOWL
1Buy$3.00+228.95%Maintains
8 months ago
Prelude Therapeutics IncPRLD
1Buy$3.00-32.28%Maintains
8 months ago
Bicycle Therapeutics PLCBCYC
1Buy$10.00+94.55%Maintains
8 months ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.